Healthcare provider profile · identity verified

Michelle Burk, D.O.

Internal Medicine · SAN FRANCISCO, CA · NPI 1962935775

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	621	231
Amlodipine Besylate	Amlodipine Besylate	371	145
Losartan Potassium	Losartan Potassium	334	124
Levothyroxine Sodium	Levothyroxine Sodium	302	96
Lisinopril	Lisinopril	198	80
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	188	44
Gabapentin	Gabapentin	174	71
Albuterol Sulfate Hfa	Albuterol Sulfate	172	91
Atenolol	Atenolol	171	67
Metformin Hcl Er	Metformin Hcl	154	56
Fluticasone Propionate	Fluticasone Propionate	140	52
Trazodone Hcl	Trazodone Hcl	128	39
Hydrochlorothiazide	Hydrochlorothiazide	117	47
Metoprolol Tartrate	Metoprolol Tartrate	117	41
Ozempic	Semaglutide	114	13
Tamsulosin Hcl	Tamsulosin Hcl	113	45
Simvastatin	Simvastatin	111	40
Duloxetine Hcl	Duloxetine Hcl	110	44
Tizanidine Hcl	Tizanidine Hcl	103	45
Furosemide	Furosemide	102	45
Sertraline Hcl	Sertraline Hcl	102	42
Ibuprofen	Ibuprofen	96	33
Famotidine	Famotidine	93	48
Metoprolol Succinate	Metoprolol Succinate	91	35
Prednisone	Prednisone	89	48
Alvesco	Ciclesonide	86	33
Omeprazole	Omeprazole	86	43
Pantoprazole Sodium	Pantoprazole Sodium	83	37
Fluoxetine Hcl	Fluoxetine Hcl	81	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	80	12
Metformin Hcl	Metformin Hcl	78	29
Potassium Chloride	Potassium Chloride	75	32
Alendronate Sodium	Alendronate Sodium	73	26
Montelukast Sodium	Montelukast Sodium	63	20
Hydrocortisone	Hydrocortisone	55	35
Lorazepam	Lorazepam	50	19
Lovastatin	Lovastatin	50	20
Rosuvastatin Calcium	Rosuvastatin Calcium	49	18
Bupropion Xl	Bupropion Hcl	47	21
Cefadroxil	Cefadroxil	47	41
Terazosin Hcl	Terazosin Hcl	47	19
Triamcinolone Acetonide	Triamcinolone Acetonide	47	30
Tramadol Hcl	Tramadol Hcl	46	21
Amoxicillin	Amoxicillin	44	28
Glipizide Er	Glipizide	44	15
Doxycycline Monohydrate	Doxycycline Monohydrate	43	36
Mirtazapine	Mirtazapine	43	22
Clopidogrel	Clopidogrel Bisulfate	42	13
Pravastatin Sodium	Pravastatin Sodium	42	14
Finasteride	Finasteride	41	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	16
Nystatin	Nystatin	40	21
Azelastine Hcl	Azelastine Hcl	39	13
Carvedilol	Carvedilol	39	11
Jardiance	Empagliflozin	38	18
Shingrix	Varicella-Zoster Ge/As01b/Pf	38	30
Allopurinol	Allopurinol	36	15
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	36	36
Glipizide	Glipizide	36	14
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	36	13
Morphine Sulfate Er	Morphine Sulfate	36	suppressed
Acyclovir	Acyclovir	35	12
Azithromycin	Azithromycin	34	32
Humalog Kwikpen U-100	Insulin Lispro	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	13
Spironolactone	Spironolactone	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	23
Pradaxa	Dabigatran Etexilate Mesylate	30	12
Lidocaine	Lidocaine	29	suppressed
Naproxen	Naproxen	29	17
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	18
Lactulose	Lactulose	28	20
Mupirocin	Mupirocin	28	14
Hydralazine Hcl	Hydralazine Hcl	27	11
Meloxicam	Meloxicam	27	11
Spiriva Respimat	Tiotropium Bromide	26	16
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	25	12
Wixela Inhub	Fluticasone Propion/Salmeterol	25	suppressed
Temazepam	Temazepam	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Ondansetron Odt	Ondansetron	23	16
Topiramate	Topiramate	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Nabumetone	Nabumetone	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	11
Buspirone Hcl	Buspirone Hcl	21	suppressed
Divalproex Sodium	Divalproex Sodium	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Chlorhexidine Gluconate	Chlorhexidine Gluconate	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	12
Estradiol	Estradiol	20	suppressed
Fluocinonide	Fluocinonide	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	20	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	19	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	18	12
Chlorthalidone	Chlorthalidone	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	11
Humulin N	Insulin Nph Human Isophane	16	suppressed
Metronidazole	Metronidazole	16	14
Propranolol Hcl	Propranolol Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	14	14
Labetalol Hcl	Labetalol Hcl	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Cephalexin	Cephalexin	13	13
Eliquis	Apixaban	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Baclofen	Baclofen	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Clonidine	Clonidine	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error